Holen Sie sich die Stockscreener-App
291.17
1.41%
-4.16
Handel nachbörslich:
291.17
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$295.33
Offen:
$293.75
24-Stunden-Volumen:
1.21M
Relative Volume:
0.71
Marktkapitalisierung:
$55.56B
Einnahmen:
$310.23B
Nettoeinkommen (Verlust:
$1.69B
KGV:
33.78
EPS:
8.62
Netto-Cashflow:
$3.58B
1W Leistung:
-0.39%
1M Leistung:
-0.31%
6M Leistung:
+29.56%
1J Leistung:
+30.86%
1-Tages-Spanne:
$289.03
$297.63
1-Wochen-Bereich:
$289.03
$302.53
52-Wochen-Spanne:
$218.65
$309.35
Cencora Inc Stock (COR) Company Profile
Firmenname
Cencora Inc
Sektor
Branche
Telefon
610-727-7000
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Vergleichen Sie COR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COR
Cencora Inc
|
291.17 | 55.56B | 310.23B | 1.69B | 3.58B | 8.62 |
|
MCK
Mckesson Corporation
|
705.45 | 88.11B | 359.05B | 3.30B | 5.23B | 25.83 |
|
CAH
Cardinal Health Inc
|
161.98 | 36.54B | 222.29B | 1.56B | 2.44B | 6.41 |
|
HSIC
Henry Schein Inc
|
74.48 | 8.92B | 12.50B | 314.00M | 421.00M | 2.44 |
|
OMI
Owens Minor Inc
|
9.29 | 623.64M | 10.42B | -38.77M | 323.54M | -0.51 |
Cencora Inc Stock (COR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-04 | Fortgesetzt | Mizuho | Outperform |
| 2024-09-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-01-03 | Eingeleitet | Barclays | Overweight |
| 2023-12-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-03-31 | Eingeleitet | Citigroup | Buy |
| 2023-01-31 | Fortgesetzt | Evercore ISI | Outperform |
| 2022-10-11 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-07-11 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-06-07 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-05-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-04-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-12 | Fortgesetzt | Evercore ISI | In-line |
| 2021-02-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-02-02 | Hochstufung | Cowen | Market Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2021-01-06 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-10 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-03 | Eingeleitet | Mizuho | Neutral |
| 2020-08-06 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-07-15 | Eingeleitet | Barclays | Underweight |
| 2020-06-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-23 | Fortgesetzt | Credit Suisse | Outperform |
| 2020-04-16 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-13 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-04-01 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-02-11 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2020-02-07 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-07-10 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-04-11 | Eingeleitet | Guggenheim | Buy |
| 2019-04-10 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-04-10 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-02-11 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-10 | Herabstufung | Jefferies | Buy → Hold |
| 2018-10-26 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-09-20 | Eingeleitet | Berenberg | Buy |
| 2018-07-17 | Fortgesetzt | Stifel | Hold |
| 2018-04-09 | Eingeleitet | MoffettNathanson | Buy |
| 2018-03-12 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-03-12 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2017-09-25 | Eingeleitet | JP Morgan | Neutral |
| 2017-09-22 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Cencora Inc Aktie (COR) Neueste Nachrichten
Three fund managers share picks for tariff-resistant U.S. stocks - The Globe and Mail
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today - Benzinga
Cencora Welcomes Lori J. Ryerkerk to Board of Directors - MSN
Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch
Is Cencora Stock Outperforming The Dow? - Barchart.com
Is Cencora Stock Outperforming the Dow? - The Globe and Mail
Cencora, Inc. (COR) Enhances Financial Flexibility with Amended Credit Agreements - GuruFocus
Cencora Enhances Financial Flexibility with Credit Amendments - TipRanks
Cencora IncIncreases Revolving Credit Facility To $4.5 Billion - MarketScreener
Cardinal Health, Cencora upgraded at Wells Fargo on industry outlook - MSN
Here's Why You Should Add Cencora Stock to Your Portfolio Now - MSN
Cravath Advises on €1B Cencora Notes Offering - Lawyer Monthly
Mizuho Adjusts Price Target on Cencora to $316 From $315, Maintains Outperform Rating - marketscreener.com
Cencora (NYSE:COR) Upgraded by Wells Fargo & Company to “Overweight” Rating - Defense World
Wells Fargo Upgrades Cencora (COR) Stock to Overweight, Lifts PT - MSN
Cencora (COR) Receives Upgrade as Analysts Set New Price Target - GuruFocus
Wells Fargo Upgrades Cencora (COR) - Nasdaq
Wells Fargo upgrades Cencora stock rating, raises price target to $337 - Investing.com Nigeria
Wells Fargo Upgrades Cencora (COR) with Raised Price Target | COR Stock News - GuruFocus
Assessing Cencora: Insights From 6 Financial Analysts - Benzinga
Cencora (COR) Receives Upgrade as Analysts Set New Price Target | COR Stock News - GuruFocus
Wells Fargo Elevates Cencora (COR) to Overweight with Raised Price Target | COR Stock News - GuruFocus
Top Cencora Executive Cashes In on Significant Stock Sale! - TipRanks
Insider Sell Alert: Lazarus Krikorian Sells 3,000 Shares of Cenc - GuruFocus
Is Cencora, Inc. (COR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
What is Zacks Research’s Estimate for Cencora Q2 Earnings? - Defense World
Cencora, Inc. Declares Quarterly Cash Dividend, Payable on June 2, 2025 - marketscreener.com
What is Zacks Research’s Estimate for Cencora Q3 Earnings? - Defense World
Nephron Research Adjusts Cencora Price Target to $335 From $325 - marketscreener.com
Cencora, Inc. (COR) Announces Board Changes: New Appointment and Resignation - GuruFocus
Cencora appoints new board member to boost growth By Investing.com - Investing.com South Africa
Cencora Announces New Board Appointment Amid Recent Resignation - TipRanks
Cencora Appoints Lori J. Ryerkerk To Board - citybiz
Cencora Elects Lori J. Ryerkerk to Its Board of Directors | COR Stock News - GuruFocus
Cencora appoints new board member to boost growth - Investing.com
Cencora Elects Lori J. Ryerkerk To Its Board Of Directors - marketscreener.com
Global Supply Chain Expert and Former Fortune 500 CEO Lori Ryerkerk Strengthens Cencora Board - Stock Titan
Baird Adjusts Price Target on Cencora to $351 From $350, Maintains Outperform Rating - marketscreener.com
Beat the Market the Zacks Way: GE Aerospace, Monster Beverage, Cencora in Focus - MSN
Cencora Completes €1 Billion Senior Notes Sale - TipRanks
Insider Sell: Steven Collis Sells Shares of Cencora Inc (COR) - GuruFocus
Cencora, Inc. (COR) Announces €1 Billion Senior Notes Offering - GuruFocus
Cencora Enters €1 Billion Senior Notes Agreement - TipRanks
Robust Results Lifted Cencora (COR) Amid Upgraded Outlook - Insider Monkey
Finanzdaten der Cencora Inc-Aktie (COR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cencora Inc-Aktie (COR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| COLLIS STEVEN H | Executive Chairman |
Jun 24 '25 |
Sale |
292.62 |
14,579 |
4,266,107 |
311,913 |
1.47%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):